Chancery Refuses Toss Of Biotech Firm Share Award Suit
By Jeff Montgomery ( November 17, 2023, 9:10 PM EST) -- Unjust enrichment and fiduciary breach claims against six directors or officers of biotech venture Northwest Biotherapeutics moved toward trial late Friday after a Delaware vice chancellor refused to dismiss claims that they failed to disclose real motives for dealing themselves more than $40 million in stock awards....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.